Welcome to CDC stacks | Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review - 33231 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Buprenorphine and Buprenorphine/Naloxone Diversion, Misuse, and Illicit Use: An International Review
  • Published Date:
    Mar 2011
  • Source:
    Curr Drug Abuse Rev. 2011; 4(1):28-41
  • Language:
    English
Filetype[PDF-90.25 KB]


Details:
No Related Documents.
You May Also Like:
  1. Evidence-based strategies for preventing opioid overdose : what’s working in the United States : an introduction for public heath, law enforcement, local organizations, and others striving to serve their community
    Personal Author:
    Carroll, Jennifer J.; Green, Traci C.; Noonan, Rita K.;
    Corporate Author:
    National Center for Injury Prevention and Control (U.S.)
    Published:
    2018
    Description:
    This document is to assist community leaders, local and regional organizers, non-profit groups, law enforcement, public health, and members of the public in understanding and navigating effective strategies to prevent opioid overdose in their communi...
    File Type:
    Filetype[PDF - 11.38 MB]
  2. Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
    Personal Author:
    Haffajee, Rebecca L.; Bohnert, Amy S.B.; Lagisetty, Pooja A.;
    Published:
    Jun 2018
    Source:
    Am J Prev Med. 54(6 Suppl 3):S230-S242
    Description:
    At least 2.3 million people in the U.S. have an opioid use disorder, less than 40% of whom receive evidence-based treatment. Buprenorphine used as part of medication-assisted treatment has high potential to address this gap because of its approval fo...
    File Type:
    Filetype[PDF - 365.78 KB]
  3. Quality improvement and care coordination : implementing the CDC guideline for prescribing opioids for chronic pain
    Corporate Author:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.. Abt Associates..
    Published:
    2018
    Description:
    The Centers for Disease Control and Prevention (CDC) aims to save lives and prevent prescription opioid misuse, opioid use disorder (OUD), and overdose by equipping providers with the knowledge, tools, and guidance they need. The purpose of this docu...
    File Type:
    Filetype[PDF - 1.83 MB]
  4. Draft CDC guideline for prescribing opioids for chronic pain, 2016 : summary of constituent comments and CDC response
    Corporate Author:
    National Center for Injury Prevention and Control (U.S.). Division of Unintentional Injury Prevention.
    Published:
    12/20/15
    Description:
    CDC hosted two constituent engagement webinars on September 16 and 17, 2015 for comment on the Draft CDC Guideline for Prescribing Opioids for Chronic Pain, 2016. Approximately 765 people participated in the live webinars and over 1200 verbal and wri...
    File Type:
    Filetype[PDF - 486.17 KB]
  5. Contextual evidence review for the CDC guideline for prescribing opioids for chronic pain – United States, 2016
    Published:
    March 18, 2016
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 65, no. RR-1
    Description:
    Contextual evidence is complementary information that assists in translating the clinical research findings into recommendations. CDC conducted contextual evidence reviews on four topics to supplement the clinical evidence review findings: : Effectiv...
    File Type:
    Filetype[PDF - 640.23 KB]